NATALEE WILLIAMS: Open Payments
NPI 1699469049 · GRETNA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,078 in 121 payments from 17 companies in 2025. Trend: 2023 $80 · 2024 $815 · 2025 $2,078
Food & beverage: $2,078
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $466 |
| Neurocrine BioSciences, Inc. | 24 | $418 |
| ACADIA Pharmaceuticals Inc | 7 | $251 |
| UCB, Inc. | 7 | $191 |
| ARGENX US, INC. | 8 | $159 |
| PFIZER INC. | 19 | $138 |
| Novartis Pharmaceuticals Corporation | 4 | $88 |
| Axsome Therapeutics, Inc. | 4 | $83 |
| Lilly USA, LLC | 3 | $64 |
| Eisai Inc. | 3 | $59 |
Products named: INGREZZA, UBRELVY, NUPLAZID, VYVGART HYTRULO, NURTEC ODT, QULIPTA, Briviact, KESIMPTA.
Industry payments across LA — which companies pay providers there.
